Leo Pharma in phase 1 with psoriasis pill
![](https://photos.watchmedier.dk/watchmedier/resize:fill:3840:0:0/plain/https://photos.watchmedier.dk/Images/article1019080.ece/ALTERNATES/schema-16_9/Leo%2520Pharma.jpg)
The Danish pharmaceutical group Leo Pharma is taking another step forward in the search for a pill-based solution for psoriasis patients. The company and its US partner, Virobay, will now be initiating phase 1 studies with an oral psoriasis treatment in-licensed by Leo Pharma in 2012, the two companies write in a joint statement.
Læs hele artiklen
Få adgang i 14 dage for 0 kr. Det kræver intet kreditkort, og du vil ikke overgå til et betalt abonnement efterfølgende.